CONCERN My Personalized Health News
E-HOME E-HEALTH SERVICES SAMPLE NEWS SUBSCRIBE FEEDBACK PRIVACY POLICY TERMS & CONDITIONS
New Users Click here to SUBSCRIBE
Newsletters Topics
» Allergy
» Alternative Medicine
» Alzheimer's Disease
» Anxiety
» Arthritis
» Asthma
» Blood Pressure
» Brain Injury Rehabilitation
» Breast Cancer
» Cancer
» Dental Care
» Depression
» Diabetes
» Exercise / Fitness
» Female Urological Disorders
» Gastrointestinal Health
» Healthy Diet
» Heart Disease
» Men's Health
» Menopause
» Neurology
» Orthopedics
» Parenting
» Rehabilitation
» Senior Caregiving
» Seniors' Health
» Skin Health
» Sleep Disorders
» Spinal Cord Rehabilitation
» Sports Medicine
» Stroke Rehabilitation
» Weight Management
» Women's Health
» Women's Heart Health
E-Health Services
» My Health Newsletter™
» My Health Reminders™
» My Health Reminders for Loved Ones™
» My Baby Expectations™
» My Health Links™
E- Services
» Latest News
» Health Highlights
» FYI
» FDA Approvals
General Information
» Click Here
Recommend These Services
username password Forgot Password?
 
 
  FDA Approvals
Return to
Daily Health Main Page.
 

  Nucleic Acid Test Screens for HIV
 
  In donated blood and tissue

 

WEDNESDAY, Dec. 31 (HealthDay News) -- The U.S. Food and Drug Administration has approved the nation's first nucleic acid test to detect the presence of HIV in donated blood and tissue.

Nucleic acid is a chemical compound that makes up the genetic material in cells. The cobas TaqScreen MPX Test screens for nucleic acid from HIV-2 and HIV-1 Group O, strains of HIV that are commonly found in Africa, the agency said in a news release. These infections also have been detected in the United States.

In addition, the test detects the most common form of the virus that causes AIDS, HIV-1 Group M, as well as two forms of hepatitis -- hepatitis C and hepatitis B.

The test is designed to be used on blood specimens obtained when the donor's heart is still beating. It's not meant to test plasma intended for further manufacturing.

The test is produced by California-based Roche Molecular Systems Inc.

More information

To learn more about HIV testing, visit the U.S. Department of Health and Human Services.

 
 
   More  FDA Approvals
 
   •  Mozobil Boosts Stem Cells Before Bone Marrow Transplants
  Could help people with certain forms of blood cancer
 
   •  Zolpimist Approved for Insomnia
  Oral spray contains Ambien's active ingredient
 
   •  Degarelix Approved for Advanced Prostate Cancer
  Suppresses testosterone production
 
   •  Gleevec Approved for Use After Cancer Surgery
  Drug first sanctioned in 2001
 
 
Health Content Provided By:
The health content is provided for informational and educational purposes. It is intended for the general population and may not reflect specific conditions or risk of an individual or segment of the population. Therefore, it is not intended to be a substitute for professional medical advice, consultation, treatment or diagnosis. Always seek the advice of your physician or other qualified health provider with questions. Never disregard professional medical advice or delay in seeking it because of information obtained through these services.
E-Home | E-Health Services | Sample News | Subscribe | Contact Us
Privacy Policy | Terms & Conditions